Clinical Trial Update: CIK Treatment for HCC Patient Underwent Radical Resection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cytokine-induced killer cell therapy for hepatocellular carcinoma following radical resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: Sun Yat-sen University | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED